Literature DB >> 10909960

Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes.

R L Bradley1, E G Kokkotou, E Maratos-Flier, B Cheatham.   

Abstract

Obesity is a common problem in Western society and is associated with significant morbidity and mortality. Energy homeostasis is regulated by a complex system involving both peripheral signals such as leptin and a number of orexigenic and anorectic neuropeptides. Obesity can result from dysregulation of the peripheral and/or central signals. Melanin-concentrating hormone (MCH) is a hypothalamic peptide that is important in the regulation of feeding behavior, primarily via uncharacterized signaling pathways in the central nervous system. Leptin, expressed in adipose tissue, mediates some of its actions through several hypothalamic neuropeptides, notably agouti-related peptide, proopiomelanocortin, and neuropeptide Y. Expression of leptin is regulated by dietary status, insulin, and glucocorticoids. Furthermore, certain neuropeptides may act on adipocytes. However, the potential effect of MCH has not been investigated. We report that MCH stimulates leptin mRNA expression and leptin secretion. MCH stimulated a 2-fold increase in leptin secretion by isolated rat adipocytes after 4 h of treatment. This increase in secreted leptin was preceded by a rapid and transient increase in ob mRNA levels; MCH stimulated a 2.5-fold increase in ob mRNA within 1 h of treatment, followed by a decline to basal levels within 4 h. In addition, we demonstrate that the MCH receptor SLC-1 is expressed in adipocytes, suggesting that fat cells may be targets of MCH or an MCH-like peptide under physiological conditions. Finally, using a radioimmunoassay, MCH/MCH-like peptide was detected in rat plasma. This study establishes a novel in vitro mammalian system for examining MCH signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909960     DOI: 10.2337/diabetes.49.7.1073

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  Orphan GPCR research.

Authors:  S Chung; T Funakoshi; O Civelli
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

2.  Effects of a novel potent melanin-concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs.

Authors:  Karolina Ploj; Lambertus Benthem; Dorota Kakol-Palm; Peter Gennemark; Liselotte Andersson; Mikael Bjursell; Jenny Börjesson; Lillevi Kärrberg; Marianne Månsson; Madeleine Antonsson; Anders Johansson; Suzanne Iverson; Björn Carlsson; Andrew Turnbull; Daniel Lindén
Journal:  Br J Pharmacol       Date:  2016-08-03       Impact factor: 8.739

Review 3.  Peptides and their potential role in the treatment of diabetes and obesity.

Authors:  Hannah C Greenwood; Stephen R Bloom; Kevin G Murphy
Journal:  Rev Diabet Stud       Date:  2011-11-10

4.  Identification and characterization of a melanin-concentrating hormone receptor.

Authors:  S An; G Cutler; J J Zhao; S G Huang; H Tian; W Li; L Liang; M Rich; A Bakleh; J Du; J L Chen; K Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Disruption of the melanin-concentrating hormone receptor 1 (MCH1R) affects thyroid function.

Authors:  Shinjae Chung; Xiao-Hui Liao; Caterina Di Cosmo; Jacqueline Van Sande; Zhiwei Wang; Samuel Refetoff; Olivier Civelli
Journal:  Endocrinology       Date:  2012-09-28       Impact factor: 4.736

6.  Mechanism of the anti-obesity effects induced by a novel melanin-concentrating hormone 1-receptor antagonist in mice.

Authors:  Masahiko Ito; A Ishihara; A Gomori; H Matsushita; Makoto Ito; J M Metzger; D J Marsh; Y Haga; H Iwaasa; S Tokita; N Takenaga; N Sato; D J MacNeil; M Moriya; A Kanatani
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

7.  Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.

Authors:  E Kokkotou; D O Espinoza; D Torres; I Karagiannides; S Kosteletos; T Savidge; M O'Brien; C Pothoulakis
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

8.  The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries.

Authors:  Hiroshi Nagasaki; Shinjae Chung; Colette T Dooley; Zhiwei Wang; Chunying Li; Yumiko Saito; Stewart D Clark; Richard A Houghten; Olivier Civelli
Journal:  Eur J Pharmacol       Date:  2008-11-17       Impact factor: 4.432

9.  Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.

Authors:  Shahryar Kiaii; Andrew J Clear; Alan G Ramsay; Derek Davies; Ajanthah Sangaralingam; Abigail Lee; Maria Calaminici; Donna S Neuberg; John G Gribben
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

10.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype.

Authors:  Gabriella Segal-Lieberman; Richard L Bradley; Efi Kokkotou; Michael Carlson; Daniel J Trombly; Xiaomei Wang; Sarah Bates; Martin G Myers; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.